Mysterious Company Drops Patent Challenge To Sanofi-Aventis' Plavix

Law360, New York (August 5, 2005, 12:00 AM EDT) -- An obscure Scottish company that had filed a mysterious challenge to the U.K. patent covering Sanofi-Aventis’ best-selling blood thinner Plavix has dropped its lawsuit, Sanofi-Aventis said Friday.

“Today Sanofi-Aventis announced that Aircoat has withdrawn the revocation action by which it had sought to invalidate the Sanofi-Aventis patent in the U.K.,” Sanofi said in a statement.

Aircoat, which is based in Scotland, started legal proceedings against Sanofi-Aventis in January this year in an attempt to overturn the patent for clopidogrel bisulfate, the main ingredient in its Plavix...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.